These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35543199)

  • 21. Nocturnal pulse rate correlated with ambulatory blood pressure and target organ damage in patients with chronic kidney disease.
    Zhang J; Wen R; Yin J; Zhu Y; Lin L; Ye Z; Peng H; Wang C; Lou T
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):77-87. PubMed ID: 30597750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
    Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
    Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum uromodulin levels, MR imaging findings, and their relationship with eGFR-based CKD staging in ADPKD patients.
    Cansever HN; Sari F; Cevikol C; Cetinkaya R; Süleymanlar G; Ersoy F
    Int Urol Nephrol; 2021 Jul; 53(7):1383-1389. PubMed ID: 33389516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension.
    Sahin A; Kocyigit I; Aslan K; Eroglu E; Demiray A; Eken A
    Clin Exp Med; 2023 Nov; 23(7):3631-3640. PubMed ID: 36869968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary renin-angiotensin markers in polycystic kidney disease.
    Salih M; Bovée DM; Roksnoer LCW; Casteleijn NF; Bakker SJL; Gansevoort RT; Zietse R; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F874-F881. PubMed ID: 28747358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-angiotensin system activation: may it increase frequency of obstructive sleep apnea in patients with autosomal dominant polycystic kidney disease?
    Yalin SF; Atahan E; Gundogdu S; Parmaksiz E; Mese M; Trabulus S; Mutlu B; Altiparmak MR
    Sleep Breath; 2023 Aug; 27(4):1359-1363. PubMed ID: 36372815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.
    Tokiwa S; Muto S; China T; Horie S
    Clin Exp Nephrol; 2011 Aug; 15(4):539-45. PubMed ID: 21431900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.
    Valero FA; Martinez-Vea A; Bardají A; Gutierrez C; Garcia C; Richart C; Oliver JA
    J Am Soc Nephrol; 1999 May; 10(5):1020-6. PubMed ID: 10232688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
    Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
    J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and predicting factors of increased arterial stiffness in autosomal dominant polycystic kidney disease.
    Sellami N; Fekih RK; Jebali H; Mami I; Smaoui W; Hmida FB; Zouaghi MK; Fatma LB; Rais L
    Saudi J Kidney Dis Transpl; 2021; 32(2):481-487. PubMed ID: 35017342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.
    Borresen ML; Wang D; Strandgaard S
    Am J Nephrol; 2007; 27(3):240-6. PubMed ID: 17389784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central blood pressure and measures of early vascular disease in children with ADPKD.
    Marlais M; Rajalingam S; Gu H; Savis A; Sinha MD; Winyard PJ
    Pediatr Nephrol; 2019 Oct; 34(10):1791-1797. PubMed ID: 31243534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
    Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
    BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of pulse pressure, pulse pressure index, and ambulatory arterial stiffness index with kidney function in a cross-sectional pediatric chronic kidney disease cohort from the CKiD study.
    Raina R; Polaconda S; Nair N; Chakraborty R; Sethi S; Krishnappa V; Kapur G; Mhanna M; Kusumi K
    J Clin Hypertens (Greenwich); 2020 Jun; 22(6):1059-1069. PubMed ID: 32472978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
    Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
    Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.